Advertisement FDA approves Glenmark generic cirrhosis drug - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

FDA approves Glenmark generic cirrhosis drug

The US Food and Drug Administrator (FDA) has approved Glenmark Generics' Ursodiol tablets as a treatment of cirrhosis in the US.

Ursodiol is a generic version of Axcan’s Urso 250mg and Urso Forte tablets.

The final approval has been given for Glenmark’s abbreviated new drug application (ANDA) for generic Ursodiol tablets USP for 250mg and 500mg strengths.

Glenmark, the US subsidiary of India-based Glenmark Pharmaceuticals, expects to begin shipping of the drug from its New Jersey facility soon.